Biomedica Immunoassays provides internationally recognized, high quality ELISAs for clinical research of cardiovascular and renal diseases and bone and mineral disorders. Biomedica has become a world-wide market leader with a continuously growing portfolio which includes ELISAs for cytokines, FGF23, NT-proBNP, (Big) Endothelin, NT-proANP, Sclerostin, OPG and FREE soluble RANKL. The majority of Biomedica’s assays are CE marked and ready for use in IVD. Biomedica’s customers include numerous top ranking scientific institutions, well-known CROs, and laboratories in the pharmaceutical industry all over the world. Additionally, service measurements can be supplied by Biomedica’s qualified and experienced laboratories on request.